Regulations.gov document
Draft Guidance for Industry on Immunogenicity-Related Considerations for the Approval of…
Other · FDA-2014-D-0310 · posted Apr 9, 2014
Key facts
| Document ID | FDA-2014-D-0310-0002 |
|---|---|
| Title | Draft Guidance for Industry on Immunogenicity-Related Considerations for the Approval of Low Molecular Weight Heparin for New Drug Applications and Abbreviated New Drug Applications |
| Document type | Other |
| Subtype | Guidance |
| Agency | FDA |
| Docket | FDA-2014-D-0310 |
| Posted | Apr 9, 2014 |
| Comment period opens | Apr 9, 2014 |
At a glance
- 1–9 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: